According to the organization, the vaccine is created and manufactured at Bharat Biotech’s BSL-3, biocontainment facility.
“This is an unprecedented vaccine trial ever to take place in India, and we are overwhelmed with the steady rise in participation. We sincerely thank all the 13000 volunteers across the country for their support in enabling us to bring out a safe and efficacious Indian vaccine for COVID-19. This pro-vaccine public health volunteerism is a morale booster for us to achieve our milestone target of 26,000 soon – Thank you volunteers Thank you India,” Bharat Biotech Joint MD Suchitra Ella mentioned.
Covaxin, India’s indigenous Covid-19 vaccine by Bharat Biotech is created in collaboration with the Indian Council of Medical Research (ICMR) — National Institute of Virology (NIV).
This indigenous, inactivated vaccine is created and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) bio-containment facility, a single of its type in the planet. Covaxin is a very purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an fantastic security track record of more than 300 million doses.